Advanced Medical Optics Inc (1168335) SEC Filing 10-K Annual report for the fiscal year ending Sunday, December 31, 2006

Abbott Medical Optics Inc

CIK: 1168335





Sheree Aronson, Corporate Vice President,

Investor Relations and Corporate Communications

(714) 247-8290


Steve Chesterman, Manager, Corporate


(714) 247-8711





Mark Levin, Manager, Investor Relations

(714) 247-8465




·      2006 Net Sales Rise 8.3% to $997.5 Million; 2006 GAAP EPS of $1.21

·      Q4 IOL Sales Rise 15.2%, Led by Tecnis® and ReZoom™  IOLs

·      $14.4 Million in Q4 Refractive IOL Sales up 62%; 2006 Sales Total $49.2 Million

·      2006 LVC Sales Growth of 76.9% Reflects VISX Acquisition, International Expansion

·      Global CustomVue Penetration Drives Q4 LVC Procedure Sales Up 14.7%

·      2006 Eye Care Sales Decline 13.1% Due to Rationalization and Recall

·      Company Reiterates 2007, 2008 Revenue and Adjusted EPS Guidance

·      Company Begins 2007 with Announcements of Strategic Acquisitions of IntraLase and WaveFront Sciences

(SANTA ANA, CA), February 13, 2007

– Advanced Medical Optics, Inc. (AMO) [NYSE: EYE], a global leader in ophthalmic surgical devices and eye care products, today announced financial results for the fourth quarter and full year 2006.

AMO 2006 net sales rose 8.3 percent to $997.5 million.  The rise reflects the May 2005 acquisition of VISX, Incorporated and subsequent international expansion of the company’s laser vision correction (LVC) business, as well as increased demand for the company’s premium intraocular lenses (IOLs) and proprietary phacoemulsification systems.  Net sales growth in 2006 was partially offset by a loss of sales following the company’s November 2006 eye care recall, a reduction in net sales related to the company’s business rationalization efforts and a 0.2 percent decline related to foreign currency.

The following information was filed by Abbott Medical Optics Inc on Tuesday, February 13, 2007 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Abbott Medical Optics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abbott Medical Optics Inc.


Assess how Abbott Medical Optics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abbott Medical Optics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1168335
Form Type: 10-K Annual Report
Accession Number: 0001104659-07-015180
Submitted to the SEC: Thu Mar 01 2007 7:02:12 AM EST
Accepted by the SEC: Thu Mar 01 2007
Period: Sunday, December 31, 2006
Industry: Surgical And Medical Instruments And Apparatus

External Resources:

Bookmark the Permalink: